„Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review”, JOHMPE, köt. 3, sz. 1, febr. 2025, doi: 10.52465/johmpe.v3i1.547.